ORTX | Orchard Therapeutics plc

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Upgrades
• Profile

Category: Consumer goods

• Industry: Biotechnology

Quick infos

• Headquarters:   United Kingdom

Trade prices

• Volume:
• Market Cap: 71.77M
• Prev closed:
• Open:
• High:
• Low:
• 52 week low:
• 52 week high:
• Dividends:

Next ER: August 11, 2022 

Top Stories (ORTX)

Earnings History

Date	EPS / Forecast	Revenue / Forecast
November 9, 2022
August 4, 2022	-0.4 / -0.2586	4.37M / 3.18M	Beat!
May 12, 2022	-0.35 / -0.25	5.52M / 4.04M	Beat!
March 30, 2022	-0.29 / -0.2725	483K / 300K	Beat!
March 17, 2022	- / -0.2725	- / 300K
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Aug 10, 2022		0.640		0.580	0.640	0.580		509.56K	8.46%
Aug 9, 2022		0.590		0.608	0.625	0.580		870.12K	-5.77%
Aug 8, 2022		0.626		0.580	0.629	0.579		1.15M	8.51%
Aug 5, 2022		0.577		0.530	0.577	0.518		1.12M	7.99%
Aug 4, 2022		0.534		0.530	0.555	0.521		691.95K	-1.95%
Aug 3, 2022		0.545		0.536	0.550	0.521		939.57K	2.79%
Aug 2, 2022		0.530		0.510	0.540	0.505		764.51K	1.38%
Aug 1, 2022		0.523		0.550	0.560	0.520		2.08M	-1.34%
Jul 29, 2022		0.530		0.557	0.570	0.511		566.96K	-3.65%
Jul 28, 2022		0.550		0.570	0.570	0.545		1.19M	-3.49%
view more

Show all

News

News for (ORTX)

• If You Had Bought Orchard Therapeutics' (NASDAQ:ORTX) Shares A Year Ago You Would Be Down 62%
  finance.yahoo.com Nov 16, 2021 11:31 am
• Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
  finance.yahoo.com Nov 16, 2021 7:00 am
• Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
  finance.yahoo.com Nov 16, 2021 7:00 am
• Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
  finance.yahoo.com Nov 16, 2021 7:00 am
• Health Check: How Prudently Does Orchard Therapeutics (NASDAQ:ORTX) Use Debt?
  finance.yahoo.com Nov 16, 2021 3:15 am
• Is Orchard Therapeutics (NASDAQ:ORTX) A Risky Investment?
  finance.yahoo.com Nov 8, 2021 11:59 am
• Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates
  finance.yahoo.com Nov 4, 2021 7:45 am
• Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
  finance.yahoo.com Sep 1, 2021 7:00 am
• Orchard Therapeutics' MPS-I Gene Therapy Shows Encouraging Action In Early Study, Shares Spike
  finance.yahoo.com Aug 18, 2021 8:19 am
• Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
  finance.yahoo.com Aug 18, 2021 7:00 am
• Orchard Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
  finance.yahoo.com Aug 18, 2021 7:00 am
• Orchard Therapeutics, Pharming Ink Development Pact For Gene Therapy
  finance.yahoo.com Jul 1, 2021 10:35 am
• Orchard Therapeutics Issues Updates On Gene Therapy Programs
  finance.yahoo.com Jun 29, 2021 11:43 am
• Column: State's biotech partner on a stem cell cure ends the project, but that's good news
  finance.yahoo.com May 28, 2021 8:12 pm
• Orchard Therapeutics Reports First Quarter 2021 Financial Results and Provides Recent Business Updates
  finance.yahoo.com May 13, 2021 7:00 am
• Be The Match BioTherapies® Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of Libmeldy
  finance.yahoo.com Mar 3, 2021 9:00 am
• Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
  finance.yahoo.com Nov 16, 2021 6:00 am
• Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID
  finance.yahoo.com Nov 16, 2021 6:00 am
• Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event
  finance.yahoo.com Sep 14, 2021 6:00 am
• Orchard Therapeutics to Host Virtual R&D Investor Event on Tuesday, September 14, 2021
  finance.yahoo.com Sep 8, 2021 7:00 am

Key Persons

Talk about Orchard Therapeutics plc below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.

Other ER on Aug 11, 2022 (Same day)